Skip to main content

Table 4 Concordance of consensus HER2 judgments by immunohistochemistry between core needle biopsy and corresponding surgically resected specimens.

From: HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens

3 categories (0 or 1+ vs. 2+ vs. 3+)

HER2 score for surgically resected specimens

Number of tumors

 

HER2 score for CNB specimens

 

0 or 1+

2+

3+

0 or 1+

56

3

1

2+

4

11

0

3+

0

5

20

% agreement = 87%, κ = 0.77, standard deviation (σ) = 0.045

2 categories (0, 1+. or 2+ vs. 3+)

HER2 score for surgically resected specimens

Number of tumors

 

HER2 score for CNB specimens

 

0, 1+ or 2+

 

3+

0, 1+, or 2+

74

 

1

3+

5

 

20

% agreement = 94%, κ = 0.83, σ = 0.038

   
  1. The judgments were performed according to the 2007 ASCO/CAP guideline.